Figure 1

![Figure 1: Schematic representation of the therapeutic mechanism of quercetin-chitosan nanoparticles (QCS) for allergic rhinitis, depicting nasal delivery, mucoadhesion, and anti-inflammatory action.]()

> Source: Dehong Mu et al. "Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic." *Scientific reports*, 2024. PMID: [38369554](https://pubmed.ncbi.nlm.nih.gov/38369554/)

<figure>
  <img src="" alt="Schematic representation of the therapeutic mechanism of quercetin-chitosan nanoparticles (QCS) for allergic rhinitis, depicting nasal delivery, mucoadhesion, and anti-inflammatory action." />
  <figcaption>Figure 1. Schematic representation of the therapeutic mechanism of quercetin-chitosan nanoparticles (QCS) for allergic rhinitis, depicting nasal delivery, mucoadhesion, and anti-inflammatory action.<br>  Source: Dehong Mu et al. "Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic." <em>Scientific reports</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38369554/">38369554</a></figcaption>
</figure>